本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Actuate Therapeutics Inc

0.2253
+0.01155.38%
盤後:0.2004-0.0249-11.05%19:56 EST
成交量:64.66萬
成交額:13.83萬
市值:1,360.42萬
市盈率:-0.29
高:0.2475
開:0.2000
低:0.2000
收:0.2138
52周最高:7.90
52周最低:0.1741
股本:6,038.28萬
流通股本:4,468.58萬
量比:0.13
換手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-0.7762
每股收益(LYR):-1.0574
淨資產收益率:-364.70%
總資產收益率:-111.91%
市淨率:-16.82
市盈率(LYR):-0.21

資料載入中...

2026/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/10/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/30

重要事件披露

Form 8-K - Current report
2026/10/28

重要事件披露

Form 8-K - Current report
2026/10/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/10/14

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/10/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/10/06

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/17

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/22

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/28

重要事件披露

Form 8-K - Current report